Publication | Closed Access

Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease

ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisHepatologyMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseNovel MarkerLiver PhysiologyMedicineMetabolic DisorderPathologyLiver DiseaseAlcohol-related Liver DiseaseFatty Liver DiseasePharmacologyAtherosclerosisDrug-induced Liver InjuryHealth Sciences